Acta Veterinaria et Zootechnica Sinica ›› 2023, Vol. 54 ›› Issue (12): 5154-5161.doi: 10.11843/j.issn.0366-6964.2023.12.025

• PREVENTIVE VETERINARY MEDICINE • Previous Articles     Next Articles

Pathogenicity of Avian Metapneumovirus Subtype B on Yellow Feather Broilers and Evaluation on Immune Effect of Inactivated Vaccine

MENG Lingzhai1, CHEN Chunli2, YU Mengmeng1, WANG Zhanxin2, WANG Suyan1, LIU Peng1, HE Tana1, GUO Ru1, CHEN Yuntong1, LIU Changjun1, QI Xiaole1, WU Zhiqiang2, GAO Yulong1*   

  1. 1. Avian Immunosuppressive Diseases Division, State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China;
    2. Guangdong Provincial Key Laboratory of Livestock and Poultry Health Breeding and Environmental Control Companies, Poultry Division Production Management Office of Wens Food Group Co., Ltd, Xinxing 527439, China
  • Received:2023-03-10 Online:2023-12-23 Published:2023-12-26

Abstract: To evaluate the protective efficacy of the inactivated vaccine against avian metapneumovirus (aMPV) subtype B in yellow-feathered broilers, the inactivated vaccine LN16-I strain prepared in this study was immunized by intramuscular injection at a dose of 0.5 mL per chicken to yellow-feathered broilers at the age of 3 weeks. Three weeks after immunization, the same injection method and dose were used once to reinforce the immunization. Serum was collected within 1-6 weeks and ELISA antibody and neutralizing antibody titers were measured. The results showed that the average ELISA antibody titer in the vaccinated group can reach 4.2×104 post-priming immunization, the average neutralizing antibody titer reached 7.42 log2, and the positive rate was 100%. Three weeks after the booster immunization, the chickens in each group were challenged with virulent virus LN16 at a dose of 5 000 TCID50 per chicken. The results showed that the chickens in the challenge control group had clinical symptoms such as cloudy or viscous nose, head shaking, and the incidence rate was 85% (11/13), while none of the chickens in the vaccinated group showed clinical symptoms. The number of virus copies in nasal swabs was further detected by RT-qPCR. The result showed that the control group chickens exhibited virus shedding, which reached a maximum at 3 days post-challenge, and the number of virus copies was 4.9×106 copies·mL-1, while the amount of virus shedding in the vaccinated group decreased by 99.43% compared with that in the control group. The pathological results showed that the turbinate and trachea of the chickens in the control group showed obvious pathological damage, while no obvious pathological changes were found in the vaccinated group. The results of this study show for the first time that the infection with aMPV subtype B can cause obvious disease in yellow-feathered broilers, and the inactivated vaccine LN16-I strain has a good immune protection effect on yellow-feathered broilers. This study provides theoretical support and technical guidance for the epidemiological investigation and effective prevention of aMPV subtype B in yellow-feathered broilers in China.

Key words: avian metapneumovirus subtype B, inactivated vaccine, yellow-feathered broiler, pathogenicity, protective efficacy

CLC Number: